Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans.
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One. 2012; 7(4):e34833.
View in:
PubMed
subject areas
Apoptosis
Apoptosis
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Fatty Acids, Monounsaturated
Fatty Acids, Monounsaturated
Gene Expression Profiling
Gene Expression Profiling
Gene Transfer Techniques
Gene Transfer Techniques
Genetic Therapy
Genetic Therapy
Humans
Humans
Lung Neoplasms
Lung Neoplasms
Maximum Tolerated Dose
Maximum Tolerated Dose
Nanoparticles
Nanoparticles
Plasmids
Plasmids
Positron-Emission Tomography
Positron-Emission Tomography
Quaternary Ammonium Compounds
Quaternary Ammonium Compounds
Reverse Transcriptase Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
Tumor Suppressor Proteins
Tumor Suppressor Proteins
authors with profiles
Rajagopal Ramesh